Combination Chemotherapy With or Without Ganitumab in Treating ...

Combination Chemotherapy with or without Ganitumab in Treating ...

Combination Chemotherapy with or without Ganitumab in Treating Patients with Newly Diagnosed Metastatic Ewing Sarcoma.

Purpose. This randomized phase III trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed ...

Randomized Phase III Trial of Ganitumab With Interval-Compressed ...

Ganitumab added to interval-compressed chemotherapy did not ... Antineoplastic Combined Chemotherapy Protocols / therapeutic use ...

Randomized Phase III Trial of Ganitumab With Interval-Compressed ...

Ganitumab added to interval-compressed chemotherapy did not significantly reduce the risk of EFS event in patients with newly diagnosed metastatic Ewing ...

COGAEWS1221: Randomized Phase 3 Trial Evaluating the Addition ...

This randomized phase III trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing ...

Randomized Phase III Trial of Ganitumab With Interval-Compressed ...

No prior trials have evaluated an IGF-1R monoclonal antibody in combination with chemotherapy for patients with Ewing sarcoma, although ...

Randomized Phase II Trial Evaluating the Addition of

This randomized phase II trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing ...

Riverside Clinical Trial Combination Chemotherapy With or Without ...

To describe the toxicity of the addition of ganitumab to multimodality therapy for patients with newly diagnosed metastatic Ewing sarcoma.~II. To compare ...

Combination Chemotherapy With or Without Ganitumab in Treating ...

NCT01473303. Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer Jun 2016 ...

Ganitumab Plus Interval-Compressed Chemotherapy Fails to ...

VDC/IE was given for 6 cycles, with or without ganitumab, as induction therapy. After local control, the chemotherapy regimen was administered ...

Combination Chemotherapy With or Without Ganitumab in Treating ...

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma Apr 2024 open_in_new. P3. National ...

Sarcoma - Project Data Sphere

It is not yet known whether adding ganitumab to combination chemotherapy is more effective in treating patients with newly diagnosed metastatic ...

Combination Chemotherapy With or Without Ganitumab in Treating ...

This randomized phase III trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing.

Ewing Sarcoma Clinical Trials - Mayo Clinic Research

This randomized phase II trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing sarcoma ...

Updates of ongoing clinical trials | MDedge Hematology and Oncology

Study summary: This randomized phase 3 trial examines whether the monoclonal antibody ganitumab plus combination chemotherapy (vincristine sulfate, doxorubicin ...

Pediatric Clinical Trials - Stanford Medicine

This randomized phase III trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing ...

UCSF Ewing Sarcoma Clinical Trials — San Francisco Bay Area

This randomized phase III trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing ...

Ganitumab and Dasatinib in Treating Patients with Relapsed or ...

Giving dasatinib and ganitumab may work better in treating patients with embryonal and alveolar rhabdomyosarcoma compared to standard treatment, including ...

Mayo Clinic Comprehensive Cancer Center — Research

It is not yet known whether combination chemotherapy is more effective with or without ganitumab in treating patients with newly diagnosed Ewing sarcoma.

UCLA Sarcoma Clinical Trials for 2024 — Los Angeles

This randomized phase III trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly ...